# American Red Cross Blood Svcs – FDA 483, May 18, 2026

Source: https://www.keypedia.com/records/483/american-red-cross-blood-svcs/13e4d979-43e2-45bc-9116-a9091d56c334

> FDA 483 for American Red Cross Blood Svcs on May 18, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: American Red Cross Blood Svcs
- Inspection Date: 2026-05-18
- Product Type: biologics
- Office Name: Atlanta District Office
- Summary: An FDA inspection of American Red Cross Blood Svcs in Asheville, NC, revealed a critical failure in the storage of blood and blood components. The firm did not store supplies in a temperature-monitored environment as required by its own procedures, and no temperature monitoring records were available. This lapse raises concerns about the integrity and safety of stored blood products.

## Related Documents

- [483 - 2020-02-27](https://www.keypedia.com/records/483/american-red-cross-blood-svcs/11c32cc8-2e45-475c-8f2c-d63cfa62495f) — date: February 27, 2020

## Related Officers

- [investigator](https://www.keypedia.com/people/randy-l-clarida/aae3cc15-a908-4489-9299-7542370ad3cd)

Company: https://www.keypedia.com/companies/american-red-cross-blood-svcs/4fef9c5b-501e-4fab-902d-47ad191da8f0

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7